DAUNORUBICIN HYDROCHLORIDE

Grunnleggende Informasjon

Element Verdi
DrugBank ID DB00694
Evidensnivå L5 (Beregningsbasert Prediksjon)
Antall Predikerte Indikasjoner 23

Predikerte Indikasjoner (TxGNN)

Følgende er potensielle nye indikasjoner predikert av TxGNN-modellen. Høyere skår indikerer høyere predikert relevans.

# Indikasjon Kilde
1 acute lymphoblastic/lymphocytic leukemia TxGNN Knowledge Graph
2 acute myeloblastic leukemia without maturation TxGNN Knowledge Graph
3 acute myeloid leukemia with t(9;11)(p22;q23) TxGNN Knowledge Graph
4 acute myeloid leukemia with NPM1 somatic mutations TxGNN Knowledge Graph
5 acute myeloblastic leukemia with maturation TxGNN Knowledge Graph
6 acute myeloid leukemia with CEBPA somatic mutations TxGNN Knowledge Graph
7 inherited acute myeloid leukemia TxGNN Knowledge Graph
8 acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor TxGNN Knowledge Graph
9 unclassified acute myeloid leukemia TxGNN Knowledge Graph
10 myeloid leukemia TxGNN Knowledge Graph
11 Kaposi's sarcoma (disease) TxGNN Knowledge Graph
12 therapy related acute myeloid leukemia and myelodysplastic syndrome TxGNN Knowledge Graph
13 acute myeloid leukemia with t(8;16)(p11;p13) translocation TxGNN Knowledge Graph
14 monocytic leukemia TxGNN Knowledge Graph
15 precursor T-cell acute lymphoblastic leukemia TxGNN Knowledge Graph
16 acute promyelocytic leukemia TxGNN Knowledge Graph
17 acute myeloid leukemia with t(8;21)(q22;q22) translocation TxGNN Knowledge Graph
18 acute myeloid leukemia with t(6;9)(p23;q34) TxGNN Knowledge Graph
19 acute myeloid leukemia with minimal differentiation TxGNN Knowledge Graph
20 leukemia, lymphocytic, susceptibility to TxGNN Knowledge Graph
21 acute erythroid leukemia TxGNN Knowledge Graph
22 acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) TxGNN Knowledge Graph
23 acute lymphoblastic leukemia (disease) TxGNN Knowledge Graph

Ansvarsfraskrivelse

Disse prediksjonene er kun for forskningsformål og utgjør ikke medisinsk rådgivning. Klinisk validering er nødvendig før enhver klinisk anvendelse.


← Tilbake til Legemiddelsøk


Back to top

Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.